Body scanning technology, which measures fat, muscle, water and bone density, has become increasingly more commonplace as an entry-level way of measuring and tracking one’s health and fitness goals. Now, first movers in the growing category are reaping the benefits. 

If the rise of peptides in popular culture were a pro sports team, BPC-157 would be its star forward. Short for 'body protection compound 157', BPC-157 has become an internet phenomenon over the past two years thanks to a flood of positive reviews by movie stars, famous podcasters, fitness influencers...

TikTok Shop’s health and beauty sales are up 84% year-over-year with around one in 10 Americans having made a purchase through the social-meets-shopping app since its 2023 e-commerce launch, according to Nielsen IQ. To find out what’s working for beauty and wellness brands now, Glossy sat down with exec Donte...

For the Wellness Briefing, Glossy spoke to Ritual CEO Kat Schneider and chief impact officer Lindsay Dahl about the company’s new ‘We’re expecting’ campaign that calls on lawmakers and Ritual consumers to advocate for stricter regulation over heavy metal contamination and clinical testing claims within the growing supplement category.

California-based Hypothesis, the 7-month-old eczema skin-care brand selling through Ulta Beauty, is targeting the acne market with the debut of a new proprietary acne ingredient and product launch.

Longtime L’Oréal Groupe executive Laura Branik joins The Glossy Beauty Podcast to discuss the strategy behind its “The Devil Wears Prada 2” partnership, including the goals, campaigns and best practices for navigating seamless product placement.

Glossy sat down with Tally Health CEO Melanie Goldey to discuss the announcement of its acquisition by Infinite Epigenetics, parent company to TruDiagnostic, maker of tools to track one’s biological age, a metric popular among biohackers to measure efficacy of longevity protocols. The acquisition announcement is part of a larger...

The Estée Lauder Companies’ new peer-reviewed study on "skin cell glycation" is set to impact the conglomerate’s longevity-focused new product pipeline and marketing initiatives on existing products. Glossy sat down with longtime ELC executive Claude Saliou to learn more.

L’Oréal Groupe CEO Nicolas Hieronimus and CFO Christophe Babule discuss the impact of the Middle East conflict, including the chance of price increases in Q2. By its CFO’s calculations, L’Oréal Groupe could lose between $105 million and $117 million from supply chain price increases caused by the conflict if it...